CD66 expression in acute leukaemia

Annals of Hematology

Volumn 79, Issue 6, 2000, Pages 299-303

  Carrasco, M ^a   Munoz L ^a   Bellido, M ^a   Bernat, S ^a   Rubiol, E ^a   Ubeda J ^a   Sierra, J ^a   Nomdedeu J F ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Acute lymphoblastic leukaemia; bcr abl; CD66; Immunophenotype; Myeloid antigens

Indexed keywords

BCR ABL PROTEIN; CARCINOEMBRYONIC ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD66 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CELL ADHESION MOLECULES; FEMALE; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; TUMOR MARKERS, BIOLOGICAL;

EID: 0343963679     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002779900146     Document Type: Article

References (23)

1. Thomson J, Grunert F, Zimmermann W (1991) Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. Clin Lab Anal 5 : 344-366
2. Madjic O (1989) CD66 cluster report. In: Knapp W, Dorken B, Gilks WR, Rieber EP, Schmidt R, Stein H, von der Borne (eds) AEGKr, leukocyte typing IV: white cell differentiation antigens. Oxford University Press, Oxford, pp 838-839
3. Watt SM, Sala-Newby G, Hoang T, Gilmore DJ, Grunert J, Nagel G, Murdoch SJ, Tchilian E, Lennox ES, Waldmann H (1991) CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules. Blood 78 : 63-74
4. Hansen L, Meyer K, Hokland P (1998) Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens. Eur J Haematol 61 : 339-346
5. Boccum P, Di Noto F, Lo Pardo C, Villa MR, Ferrara F, Rotoli B, Del Vecchio L (1998) CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies. Tissue Antigens 52 : 1-8
6. Drach J, Drach D, Glassl H, Gattringer C, Huber H (1992) Flow cytometric determination of atypical antigen expression in acute lymphoblastic leukemia for the study of minimal residual disease. Cytometry 13 : 893-901
7. Hanenberg H, Baumann M, Quentin I, Nagel G, Grosse-Wilde H, von Kleist S, Göbel U, Burdach S, Grunert F (1994) Expression of the CEA gene family members NCA-50/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukemias (ALLs) and in cell lines of B-cell origin. Leukemia 8 : 2127-2133
8. Hann WL, Richards SM, Eden OB, Hill FGH (1998) Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukemia Trial XI (MCR UKALLXI). Leukemia 12 : 1249-1255
9. Kammerer R, Hahn S, Singer BB, Luo JS, Von Kleist S (1998) Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation. Eur J Immunol 28 : 3664-3674
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galto DA, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 103 : 620-624
11. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB (1995) Proposals for the immunological classification of acute leukemias. Leukemia 9 : 1783-1786
12. Bene MC, Bernier M, Casanovas RO, Castoldi G, Knapp W, Lanza F, Ludwing WD, Matutes E, Orfito A, Sperling C, van't Veer MB for EGIL (1998) The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. Blood 92 : 596-599
13. Nomdedeu JF, Mateu R, Altés A, Llorente A, Rio C, Estivill C, López O, Ubeda J, Rubiol E (1999) Enhanced myeloid specificity of CD117 compared with CD 13 and CD33. Leuk Res 23 : 341-347
14. Ciudad J, San Miguel JF, López-Berges MC, García Marcos MA, Gonzalez M, Vazquez L, Del Cañizo MC, López A, Van Dongen JJM, Orfao A (1999) Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL. Br J Haematol 104 : 695-705
15. Lucio P, Parreira, A, van den Beemd MWL, van Lochem EG, van Wering E, Baarrs E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Orfao A, Janossy G, van Dongen JJM, San Miguel JM (1999) Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor B-ALL. Leukemia 13 : 419-427
16. Mitelman F (ed) (1995) ISCN an international system for human cytogenetic nomenclature. Karger, Basel
17. Saglio G, Pane F, Gottardi E, Frigeri F, Buonaiuto MR, Guerrasio A, De Micheli D, Parziale A, Forcani MN, Martinelli G, Salvatore F (1996) Consistent amounts of acute leukemia-associated p190 bcr/ab1 transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 87 : 1075
18. Boldt DK, Kopecky KJ, Head D, Gehly G, Radich JP, Appelbaum FR (1994) Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group Experience. Leukemia 12 : 2118-2126
19. Cuneo A, Demuynck H, Ferrant A, Louwagie A, Doyen C, Stul M, Cassiman JJ, Dal Cin P, Negrini M, Carli MG, Boogaerts M, Michaux JL, Castoldi G, van den Berghe H (1994) Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukaemia: correlation with cytogenetic pattern and implication for poor response therapy. Br J Haematol 87 : 515-522
20. Lauria F, Raspadori D, Martinelli G, Rondelli D, Ventura MA, Farabegoli P, Tosi P, Testoni N, Visani G, Zaccaria A, Gamberi B, Cenachi A, Tura S (1994) Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications. Br J Haematol 87 : 286
21. Putti MC, Rondelli R, Cocito MG, Aricó M, Sainati L, Conter V, Gugliemi C, Cantfa-Rajnoldi A, Consolini R, Pession A, Zanesco L, Masera G, Biondi A, Basso G (1998) Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood 92 : 795-801
22. Campana D, Coustan-Smith E, Janossy G (1990) The immunologic detection of minimal residual disease in acute leukemia. Blood 76 : 163-171
23. Coustan-Smith E, Behm FG, Sanchez J, Boyett J, Hancock M, Raimondi S, Rubnitz J, Rivera G, Sandlund J, Pui C, Campana D (1998) Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 35 : 550-554